Pharma & Biotech - Page 22

The US Food and Drug Administration is launching a formal assessment of small dispensers’ ability to conduct interoperable, package-level product tracing under the Drug Supply Chain Security Act. The assessment targets pharmacies

Injected weight loss treatments continue to dominate physician preferences, with Eli Lilly’s (LLY) Zepbound leading the field despite a wave of new oral obesity medications arriving on the market. A Spherix Global

Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist 2 mg/1 mL due to a label mix-up. The recall centres on

Takeda Pharmaceutical has secured a significant regulatory milestone after its first-in-class orexin treatment received approval from the US Food and Drug Administration for narcolepsy. The approval marks a major breakthrough in narcolepsy

Takeda has secured FDA approval for Orzeyful, a twice-daily tablet treating narcolepsy type 1 in adults, making it the first medicine of its kind. Unlike existing narcolepsy treatments that address symptoms, Orzeyful

AstraZeneca and Bristol Myers Squibb have seen days of intense merger speculation brought to an abrupt halt by a senior source close to the matter. A person familiar with the situation told

Sarepta Therapeutics has appointed Michael Severino, M.D., as its new chief executive, effective July 28, replacing longtime leader Doug Ingram. Ingram announced his planned retirement citing what he described as an “ironic

CVS Health (CVS) is overhauling its direct-to-consumer weight management programme, cutting the price of MinuteClinic weight-management visits to just $29 per appointment. The healthcare giant is also rolling out pharmacist support across

Fujifilm Biotechnologies has announced a significant leadership transition, naming Maja Pedersen as President in addition to her existing role as Chief Operating Officer. The appointment takes effect immediately and marks a deliberate

ViiV Healthcare, the global specialist HIV company majority owned by GSK (GSK), has launched a new multichannel campaign called “Do It For Future You” aimed at encouraging people to act on their